LGALS3 and COVID-19: (30), despite the observed higher mean value of Gal-3 serum levels in COVID-19 patients presenting cardiac function deterioration compared to those without cardiac complications, this difference was not statistically significant (Gal-3 levels between patients showing or non-showing cardiac complications: 4.7 ± 2.7 ng/mL vs. 3.5 ± 1.6 ng/mL, P = 0.35).